NIH Funds $4M Study on Early Triggers of Lupus and Autoimmune Diseases
Key Questions
What is the focus of the University of Houston's NIH-funded lupus study?
The $4M NIH grant supports a 10-year longitudinal study on early triggers of systemic autoimmune rheumatic diseases including lupus. Led by Chandra Mohan, it aims to identify shared molecular pathways in pre-clinical autoimmunity.
How could this research improve lupus outcomes?
By detecting early molecular changes, the study may enable earlier intervention and prevention strategies before full disease onset. This aligns with increasing interest in proactive lupus management.
When was the University of Houston grant announced?
The University of Houston announced receipt of the $4 million NIH grant on July 6 for the autoimmune disease research project.
University of Houston receives $4M NIH grant for a 10-year longitudinal study on early triggers of systemic autoimmune rheumatic diseases (SARDs) including lupus. Led by Chandra Mohan, the study aims to identify shared molecular pathways in pre-clinical autoimmunity, potentially enabling earlier intervention and prevention strategies. This aligns with growing interest in early detection and prevention in lupus.